Trial update
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2): registry status update
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.